This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Maria G. M. Hunink, MD, PhD; Lee Goldman, MD, MPH; Milton C. Weinstein, PhD
Harvard School of Public Health Boston, Mass

JAMA. 1997;277(21):1678.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—Dr Rumm and colleagues are incorrect in their assertion that our model was designed to favor treatment over prevention. In fact, we modeled known changes in risk factors and in outcomes of treatment to determine whether these changes could explain the known decline in mortality. As with any model, it is possible that any of our estimates could be incorrect, but we provided detailed information for peer review and believe it is inappropriate to claim we were somehow biased in favor of treatment over prevention. As we acknowledge in the Comment section, trends in aspirin use, estrogen replacement therapy, and exercise regimens may be important factors that we omitted from our analysis. Although causes other than risk factors or medical interventions may have played a major role as suggested by Rumm and colleagues, this remains speculative in the absence of data to support such a statement with respect to CHD . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?